| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.00018 | 1 |